Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dividend Growth Investing and chit chat. -- Ignore unavailable to you. Want to Upgrade?

To: Jacob Marley who wrote (1373)	12/5/2021 11:44:02 AM
From: 5-88	Respond to of 2146

RE: MRK & AMGN -------------------------------------------- I don't think you could go wrong with either one over time. I own both and would add more here myself. I may purchase $2K in AMGN tomorrow or just buy more MO.

To: Jacob Marley who wrote (1373)	12/5/2021 12:26:04 PM
From: chowder	3 Recommendations Recommended By cal77 Jacob Marley Menominee Respond to of 2146

Re: MRK vs AMGN Analysts seem to favor MRK a little more in the near term, there's not a lot of difference regarding ratings. It then comes down to whether you would prefer investing in pharmaceuticals or biotechnology. This is actually the first thing I look at, I call it what a company does for a living. Where I might avoid pharmaceuticals I wouldn't consider MRK but if I were looking to buy pharma I'd compare MRK to its peers and if had better numbers than its peers I'd own it. They both look good at this time at least from a ratings point of view.

To: Jacob Marley who wrote (1373)	12/5/2021 4:12:29 PM
From: DaveVK	Respond to of 2146

I also own both. I would add to either here, depending on each one's weight in my portfolio. Rather than most recent increase %, I would often tend to look at which one adds more dividend dollars $ to my income stream. Dave